# Silk Road Medical Inc. (SILK)

Source: https://www.quantisnow.com/company/SILK
Generated: 2026-11-12T07:53:13.838Z

- Ticker: SILK
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Medical/Dental Instruments
- IPO year: 2019
- Website: silkroadmed.com

## About

Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products includes ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; and ENROUTE 0.014 Guidewire for navigating and crossing the target lesion for delivery of interventional devices. The company was incorporated in 2007 and is headquartered in Sunnyvale, California.

## Latest SILK news and filings

- 2024-10-23 10:30 UTC [Earnings Date] [Boston Scientific Announces Results for Third Quarter 2024](https://www.quantisnow.com/insight/boston-scientific-announces-results-for-third-quarter-2024-5734285)
- 2024-09-27 20:00 UTC [SEC Form 15-12G filed by Silk Road Medical Inc.](https://www.quantisnow.com/insight/sec-form-15-12g-filed-by-silk-road-medical-inc-5706932)
- 2024-09-24 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Silk Road Medical Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-silk-road-medical-inc-5702636)
- 2024-09-19 12:16 UTC [SEC Schedule 13D] [Amendment: SEC Form SC 13D/A filed by Silk Road Medical Inc.](https://www.quantisnow.com/insight/amendment-sec-form-sc-13da-filed-by-silk-road-medical-5699136)
- 2024-09-19 01:12 UTC [SEC Form 4] [Director Zurbay Donald returned 12,610 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/director-zurbay-donald-returned-12610-shares-to-the-company-closing-5698791)
- 2024-09-19 01:08 UTC [SEC Form 4] [Director Weatherman Elizabeth H returned 155,004 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/director-weatherman-elizabeth-h-returned-155004-shares-to-the-company-5698789)
- 2024-09-19 01:01 UTC [SEC Form 4] [Director Lasersohn Jack W returned 16,735 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/director-lasersohn-jack-w-returned-16735-shares-to-the-company-5698788)
- 2024-09-19 00:56 UTC [SEC Form 4] [Director Chou Tony M. returned 85,251 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/director-chou-tony-m-returned-85251-shares-to-the-company-5698786)
- 2024-09-19 00:52 UTC [SEC Form 4] [Director Carino Tanisha returned 11,396 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/director-carino-tanisha-returned-11396-shares-to-the-company-closing-5698783)
- 2024-09-19 00:48 UTC [SEC Form 4] [Director Ballinger Kevin J. returned 23,666 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/director-ballinger-kevin-j-returned-23666-shares-to-the-company-5698782)
- 2024-09-19 00:44 UTC [SEC Form 4] [Director Anderson Rick D returned 11,966 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/director-anderson-rick-d-returned-11966-shares-to-the-company-5698778)
- 2024-09-19 00:40 UTC [SEC Form 4] [EVPClin&Reg.Affairs&QA Ruedy Richard returned 232,031 shares to the company and was granted 26,250 shares, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/evpclinregaffairsqa-ruedy-richard-returned-232031-shares-to-the-company-and-5698774)
- 2024-09-19 00:35 UTC [SEC Form 4] [VP, Finance and CAO Jones Marie L. returned 79,266 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/vp-finance-and-cao-jones-marie-l-returned-79266-shares-5698773)
- 2024-09-19 00:31 UTC [SEC Form 4] [EVP/Chief Legal Officer/Sec. Klemz Kevin M returned 191,988 shares to the company and was granted 29,062 shares, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/evpchief-legal-officersec-klemz-kevin-m-returned-191988-shares-to-5698771)
- 2024-09-19 00:27 UTC [SEC Form 4] [Chief Commercial Officer Davis Andrew S. returned 332,295 shares to the company and was granted 42,218 shares, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/chief-commercial-officer-davis-andrew-s-returned-332295-shares-to-5698770)
- 2024-09-19 00:23 UTC [SEC Form 4] [COO & CFO Buchanan Lucas W. returned 567,689 shares to the company and was granted 50,876 shares, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/coo-cfo-buchanan-lucas-w-returned-567689-shares-to-the-5698768)
- 2024-09-19 00:19 UTC [SEC Form 4] [Chief Executive Officer Mckhann Chas returned 2,021,438 shares to the company and was granted 1,299,042 shares, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/chief-executive-officer-mckhann-chas-returned-2021438-shares-to-the-5698764)
- 2024-09-17 13:33 UTC [SEC Form 25-NSE filed by Silk Road Medical Inc.](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-silk-road-medical-inc-5696195)
- 2024-09-17 13:12 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Silk Road Medical Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-silk-road-medical-inc-5696170)
- 2024-09-17 13:12 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Silk Road Medical Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-silk-road-medical-inc-5696169)
- 2024-09-17 13:12 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Silk Road Medical Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-silk-road-medical-inc-5696168)
- 2024-09-17 13:12 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Silk Road Medical Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-silk-road-medical-inc-5696167)
- 2024-09-17 13:12 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Silk Road Medical Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-silk-road-medical-inc-5696166)
- 2024-09-17 13:12 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Silk Road Medical Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-silk-road-medical-inc-5696165)
- 2024-09-17 12:46 UTC [SEC Form POS AM filed by Silk Road Medical Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-silk-road-medical-inc-5696072)
- 2024-09-17 12:46 UTC [SEC Form 8-K] [Silk Road Medical Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Events That Accelerate or Increase a Direct Financial Obligation, Leadership Update, Financial Statements and Exhibits](https://www.quantisnow.com/insight/silk-road-medical-inc-filed-sec-form-8-k-termination-of-5696071)
- 2024-09-17 12:31 UTC [Boston Scientific Closes Acquisition of Silk Road Medical, Inc.](https://www.quantisnow.com/insight/boston-scientific-closes-acquisition-of-silk-road-medical-inc-5696060)
- 2024-09-13 10:01 UTC [SEC Form 8-K] [SEC Form 8-K filed by Silk Road Medical Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-silk-road-medical-inc-5692799)
- 2024-09-06 00:39 UTC [SEC Form 8-K] [SEC Form 8-K filed by Silk Road Medical Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-silk-road-medical-inc-5685136)
- 2024-08-28 10:01 UTC [SEC Form DEFR14A filed by Silk Road Medical Inc.](https://www.quantisnow.com/insight/sec-form-defr14a-filed-by-silk-road-medical-inc-5674071)
- 2024-08-21 21:12 UTC [SEC Form 4] [EVP/Chief Legal Officer/Sec. Klemz Kevin M sold $61,470 worth of shares (2,268 units at $27.10), decreasing direct ownership by 1% to 162,926 units (SEC Form 4)](https://www.quantisnow.com/insight/evpchief-legal-officersec-klemz-kevin-m-sold-61470-worth-of-5668177)
- 2024-08-19 19:29 UTC [SEC Form 144] [SEC Form 144 filed by Silk Road Medical Inc.](https://www.quantisnow.com/insight/sec-form-144-filed-by-silk-road-medical-inc-5664235)
- 2024-08-19 13:31 UTC [SILK Alert: Monsey Firm of Wohl & Fruchter Renews Investigation of the Proposed Sale of Silk Road Medical to Boston Scientific](https://www.quantisnow.com/insight/silk-alert-monsey-firm-of-wohl-fruchter-renews-investigation-of-5664005)
- 2024-08-12 20:21 UTC [SEC Schedule 13D] [SEC Form SC 13D filed by Silk Road Medical Inc.](https://www.quantisnow.com/insight/sec-form-sc-13d-filed-by-silk-road-medical-inc-5655038)
- 2024-08-09 21:08 UTC [SEC Form 8-K] [Silk Road Medical Inc. filed SEC Form 8-K: Other Events](https://www.quantisnow.com/insight/silk-road-medical-inc-filed-sec-form-8-k-other-events-5653427)
- 2024-08-07 20:16 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Silk Road Medical Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-silk-road-medical-inc-5647777)
- 2024-08-07 20:07 UTC [SEC Form 8-K] [Silk Road Medical Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/silk-road-medical-inc-filed-sec-form-8-k-results-of-5647442)
- 2024-08-07 20:05 UTC [Silk Road Medical Reports Second Quarter 2024 Financial Results](https://www.quantisnow.com/insight/silk-road-medical-reports-second-quarter-2024-financial-results-5647287)
- 2024-07-30 12:00 UTC [Silk Road Medical Celebrates Milestone of 100,000 Transcarotid Artery Revascularization (TCAR) Procedures](https://www.quantisnow.com/insight/silk-road-medical-celebrates-milestone-of-100000-transcarotid-artery-revascularization-5632405)
- 2024-07-29 10:01 UTC [SEC Form DEFM14A] [SEC Form DEFM14A filed by Silk Road Medical Inc.](https://www.quantisnow.com/insight/sec-form-defm14a-filed-by-silk-road-medical-inc-5630456)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/SILK
- Earnings history: https://www.quantisnow.com/earnings/SILK
- Dividend history: https://www.quantisnow.com/dividends/SILK
- Insider transactions: https://www.quantisnow.com/insiders/SILK
- Options chain: https://www.quantisnow.com/options/SILK
- SEC 8-K filings only: https://www.quantisnow.com/company/SILK/8-k
- RSS and alerts for SILK: https://www.quantisnow.com/docs/rss-feeds.md